Here is what the page “Why Demand for the Shingles Vaccine Is Soaring: Can It Help Prevent Dementia?” contains. Demand for the shingles vaccine is surging across Britain, driven by growing hopes that it might also protect against dementia. High street chemists report a rise in inquiries, with many under-65s paying around £450 for the full two-dose course, as they seek to reduce their risk of cognitive decline. The interest is fueled by emerging research suggesting a link between the shingles vaccine and a lower risk of dementia, though experts caution the evidence is not yet conclusive.
Jenny, a 50-year-old marketing professional from Cambridge, is among those motivated by family history. Having seen three grandparents suffer from dementia, she opted for the vaccine hoping it might offer some protection. Her story reflects a wider trend of people prioritizing brain health in their preventive care decisions. For the complete material, the listing points back to the source inside the network.